NS · Healthcare

Mono Pharmacare Ltd (MONOPHARMA)

Pharmaceuticals & Biotechnology

Mono Pharmacare Ltd (MONOPHARMA) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $194.40M, P/E ratio is 23.80. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MONOPHARMA

Market cap

$194.40M

P/E ratio

23.80

Mono Pharmacare Ltd (MONOPHARMA) — FAQ

What is Mono Pharmacare Ltd's market cap?

Mono Pharmacare Ltd (MONOPHARMA) has a reported market cap of $194.40M (data as of 2026-07-10).

What is MONOPHARMA's P/E ratio?

The price-to-earnings (P/E) ratio for Mono Pharmacare Ltd (MONOPHARMA) is 23.80 (data as of 2026-07-10).

Does Mono Pharmacare Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Mono Pharmacare Ltd (MONOPHARMA). Check the MyAverix Finance app for the latest dividend data.

What sector is Mono Pharmacare Ltd in?

Mono Pharmacare Ltd (MONOPHARMA) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is MONOPHARMA listed on?

MONOPHARMA is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)